Nanoclay-reinforced HA/alginate scaffolds as cell carriers and SDF-1 delivery-platforms for bone tissue engineering

dc.contributor.authorErezuma, Itsasne
dc.contributor.authorLukin, Izeia
dc.contributor.authorPimenta Lopes, Carolina
dc.contributor.authorVentura Pujol, Francesc
dc.contributor.authorGarcia Garcia, Patricia
dc.contributor.authorReyes, Ricardo
dc.contributor.authorArnau, Rosa M.
dc.contributor.authorDelgado, Araceli
dc.contributor.authorTaebnia, Nayere
dc.contributor.authorBabu Kadumudi, Firoz
dc.contributor.authorDolatshahi Pirouz, Alireza
dc.contributor.authorOrive, Gorka
dc.date.accessioned2022-07-18T17:10:09Z
dc.date.available2022-07-18T17:10:09Z
dc.date.issued2022-06-01
dc.date.updated2022-07-18T08:13:43Z
dc.description.abstractBone tissue engineering has come on the scene to overcome the difficulties of the current treatment strategies. By combining biomaterials, active agents and growth factors, cells and nanomaterials, tissue engineering makes it possible to create new structures that enhance bone regeneration. Herein, hyaluronic acid and alginate were used to create biologically active hydrogels, and montmorillonite nanoclay was used to reinforce and stabilize them. The developed scaffolds were found to be biocompatible and osteogenic with mMSCs in vitro, especially those reinforced with the nanoclay, and allowed mineralization even in the absence of differentiation media. Moreover, an in vivo investigation was performed to establish the potential of the hydrogels to mend bone and act as cell-carriers and delivery platforms for SDF-1. Scaffolds embedded with SDF-1 exhibited the highest percentages of bone regeneration as well as of angiogenesis, which confirms the suitability of the scaffolds for bone. Although there are a number of obstacles to triumph over, these bioengineered structures showed potential as future bone regeneration treatments.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec729814
dc.identifier.pmid35691524
dc.identifier.urihttps://hdl.handle.net/2445/187842
dc.language.isoeng
dc.publisherElsevier BV
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.ijpharm.2022.121895
dc.relation.ispartofInternational Journal of Pharmaceutics, 2022, vol. 623, p. 121895
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/951747/EU//GREENELIT
dc.relation.urihttps://doi.org/10.1016/j.ijpharm.2022.121895
dc.rightscc by (c) Erezuma, Itsasne et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Ciències Fisiològiques)
dc.subject.classificationEnginyeria de teixits
dc.subject.classificationOssos
dc.subject.classificationMaterials biomèdics
dc.subject.otherBones
dc.subject.otherBiomedical materials
dc.subject.otherTissue engineering
dc.titleNanoclay-reinforced HA/alginate scaffolds as cell carriers and SDF-1 delivery-platforms for bone tissue engineering
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
1-s2.0-S0378517322004501-main.pdf
Mida:
11.73 MB
Format:
Adobe Portable Document Format